Oral mucositis is a common morbidity induced by radiation therapy and/or chemotherapy for head and neck malignancies. This often results in treatment delays, premature treatment cessation and increased cost. New treatments for oral mucositis are emerging but their success is variable. This is a case report of oral mucositis in Non-Hodgkin's Lymphoma (NHL) reported after 11 th fraction of radiotherapy. Chief complaints were ulceration of mouth with painful swallowing. Clinical diagnosis as per the World Health Organization Grading Scale was Grade 3 oral mucositis. Phytolacca 30C was prescribed on the basis of acute totality of symptoms. Ulcers were reduced considerably within 4 days and radiotherapy was restarted and 22 fractions of radiation were completed. This case report suggests that homoeopathic intervention may be the treatment for mucositis in cancer patients undergoing radiation treatment.
INTRODUCTION
Non-Hodgkin's Lymphoma (NHL) includes a heterogeneous group of lymphoproliferative disorders. The primary treatment for NHL includes chemotherapy, radiation, immunotherapy and stem cell transplant. The side effects from radiation therapy will depend on the area being treated. Patients can expect to have dry mouth, mouth sores, esophagitis and dysphagia if head and neck region is being irradiated. [1] Oral mucositis is a common complication of cancer therapy and incidence ranges between 80% and 97%. [1] [2] [3] Incidence of Grade 3-4 mucositis may be up to 40%-55% depending upon type of radiotherapy and concomitant use of chemotherapy. [4, 5] The severity of oral mucositis is high in patients having primary tumours in the oral cavity, oropharynx or nasopharynx. Use of concurrent chemotherapy, total radiotherapy dose >50Gy, altered fractionation radiation schedules (e.g., more than one radiation treatment per day) are known to increase the incidence and severity of oral mucositis. [4, 6, 7] Lesions of oral mucositis are often very painful and compromise nutrition and oral hygiene as well as increase the risk for local and systemic infection. Mucositis may limit the patient's ability to tolerate chemotherapy or radiation therapy and signifi cantly affects patient's quality of life (QoL). [8] Severe oral toxicities can also compromise the delivery of optimal cancer therapy protocols, since treatment dose reduction or schedule modifi cations may be necessary to allow for resolution of oral lesions. In cases of severe oral morbidity, the patient may no longer be able to complete the recommended cancer therapy. These disruptions in cancer treatment due to oral complications can directly affect patient survivorship. Mucositis score is used to measure and convey the toxicity of a particular therapy which serves as a nursing management tool and is used to determine the effi cacy of new treatments for the condition. The commonly used assessment tools are the World Health Organization (WHO) grading, Radiation Therapy Oncology Group grading, Oral Mucositis Assessment Scale and The National Cancer Institute Common Toxicity Criteria. [9] [10] [11] 
CASE REPORT History
A 55-year-old male (teacher by occupation), known case of NHL (high grade) was admitted to Delhi State Cancer Institute (DSCI) and Hospital on 4 th May 2016 for the complaint of ulceration in oral cavity after 11 th fraction of radiotherapy. Following allopathic medicines were prescribed for 8 days but there was no relief: tablet Ciprofl oxacin 200mg/BD, injection Metrogyl 4mg/TDS, injection Forcan 100mg/OD, injection Tramedol 100mg/BD, injection Pantop OD, injection Emset BD, injection Lasix, Betadine mouth gargles, Zylee lotion LA, syrup Muccogel 2 tsp/OD. On 11 th May 2016, the case was referred by a consultant to the homoeopathic unit with presenting complaints of ulceration in mouth with painful swallowing, pain radiating to ears on swallowing, feeling of roughness of throat with burning pain, feeling of heat in the throat with scanty stringy saliva since 4-5 days. Severe soreness and dryness of throat were present with aggravation in morning. The patient was thirsty with desire for cold water but was unable to drink, blood pressure was 160/100 mmHg, and pulse rate was 98 per/min. Laboratory tests showed white blood cell count of 4.19μL, haemoglobin level of 5.44 g/dl, platelets of 343 × 10 9 /L, differential leucocyte count -neutrophil -69.7%, lymphocytes-11.4%, monocytes-10.8%, eosinophils-5.3%, basophils-0.6%. Biopsy (oropharynx) revealed diffuse large B cell NHL (high grade), BCL-2+ve and weak CD20+ve.
Examination
Oral mucosa was hyperaemic and congestion was seen on posterior aspect of hard, soft palate. Buccal mucosa having yellowish deposits with offensive smell. Tongue was reddish and dry. Small ulcerated patches were seen. On upper surface, there were dark bluish patches.
WHO grading was Grade 3.
Intervention
Homoeopathic medicine Phytolacca 30C procured from GMP certifi ed manufacturer was dispensed in water doses every 2 hourly (6 doses) for 1 day on the basis of acute totality. The symptoms were graded as frequency intensity and duration [12] which comprised of ulcers on the tongue and throat with painful swallowing 3+; pain radiating to ears on swallowing 3+; feeling of roughness of throat with burning pain 3+; dark redness of oral cavity with congestion on posterior aspect of hard, soft palate and buccal mucosa 3+; tongue red with dark bluish patches on upper surface 2+.
Follow-up and outcomes
The follow up and outcomes after administration of homoeopathic medicine is given at Table 1 .
DISCUSSION
Conventional management of oral mucositis has been largely palliative to date. In this case, homoeopathic medicine Phytolacca 30, prescribed on the basis of acute totality resolved the mucositis (WHO Grade 0) within 4 days, whereas usually Grade 3 mucositis takes 3-6 weeks to resolve. [13] [14] [15] Oral mucositis is a common, debilitating complication of cancer chemotherapy and radiotherapy. The development of Grade 3 mucositis warrants stoppage of radiotherapy as further injury to the mucosa causes its permanent damage. [16] It has been demonstrated that patients with oral mucositis are signifi cantly more likely to have severe pain and a weight loss of ≥5%. [17] Justifi cation of medicine Phytolacca includes Ulceration of mouth with pain radiating to ears on swallowing, feeling of roughness of throat with burning pain, dark redness or bluish redness of throat, tonguered tip, feeling rough and scalded. Bluish patches on the tongue were identifi ed. Ulcerated sore throat cannot swallow even food and water. [18] Although Arsenic, Merc, Lach, Nat mur and Phosphorus were also closely indicated medicines for condition but not considered because Arsenic -absence of restlessness; Merc -thirst was not so marked; Lachesis -diffi culty of swallowing present for both liquids and food; left-sided affection was not there and aggravation for touch and pressure was not there; Nat mur absence of mapped tongue; Phosphorus-bleeding from gums and ulcers, thirst for very cold water were not present.
Case was also assessed as per the Modifi ed Naranjo Criteria, which suggest the causal relation between the intervention and outcome and the score was 8. [19] However, limitation of the case includes lack of objective evidences i.e., photographs and QoL scale.
This case shows the utility of Homoeopathy to treat radiation-induced mucositis. Homoeopathic medicines can help reduce the symptom burden, thereby improving QoL and compliance to radiation treatment. Homoeopathy can help reduce unscheduled radiation treatment breaks, which prolongs the total radiation treatment time, compromises on the efficacy of therapy and results in diminished treatment outcomes as well as reduced QoL. Economic burden is a major issue. The per patient incremental cost of Grade 1-2 oral mucositis can be as high as $1700 and that of Grade 3-4 oral mucositis can rise upto $6000. [20] Nonzee et al.'s analysis which was limited to severe oral mucositis (Grade 3-4) found the incremental cost per patient to be $17,000. [21] Reduction in days of hospitalization due to mucositis and costs can be effectively managed through homoeopathic treatment.
CONCLUSION
Homoeopathy can play a key role in treatment of radiation-induced mucositis, thereby reducing radiation treatment breaks, days of hospitalization, improving adherence to radiation therapy. Further studies on appropriate sample are required to establish the effi cacy of Homoeopathic intervention in radiation-induced mucositis patient.
Patient perspective
I was in ogonizing pain when I was under radiotherapy. I couldn't eat for days but after the homoeopathy treatment, I not only started eating, my ulcers were also cured completely.
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Résumé
La mucosite buccale, parfois mortelle, est un des effets secondaires les plus courants des traitements par radiothérapie et/ ou chimiothérapie des cancers de la tête et du cou. Elle conduit souvent à des retards de traitement, à l'arrêt prématuré du traitement et à une augmentation des coûts. De nouveaux traitements de la mucosite buccale font leur apparition mais leur succès est variable. Nous présentons ici une étude de cas de mucosite buccale dans un cas de lymphome non hodgkinien (LNH) signalé après la 11e fraction de radiothérapie. Les principaux symptômes étaient l'ulcération de la bouche et une déglutition douloureuse. Le diagnostic clinique selon la classifi cation de l'Organisation mondiale de la Santé était une mucosite buccale de grade III. Du Phytolacca 30°C a été prescrit sur la base de l'ensemble des symptômes aigus. Au bout de 4 jours, les ulcères avaient considérablement réduit, la radiothérapie a recommencée et 22 fractions ont été administrées. Cette étude de cas suggère que l'intervention homéopathique pourrait être le traitement des mucosites chez les patients atteints de cancers subissant des traitements de radiothérapie.
